Restoring Dystrophin via Exon Skipping Strategies AOC 1044 – Mark Stahl, MD (Avidity Biosciences) BMN 351 – Dave Jacoby MD, PhD (BioMarin Pharmaceutical Inc.) DYNE-251 – Ash Dugar, PhD, MBA (Dyne Therapeutics) ED051 – Michelle Mellion, MD (PepGen, Inc.) ENTR-601-44 – Nerissa Kreher, MD, MBA (Entrada Therapeutics) SRP-5051 – Teji Singh, MD (Sarepta Therapeutics) WVE-N531 – Mike Panzara, MD, MPH (Wave Life Sciences) 2022 PPMD Annual Conference,Conferences & Meetings 3 years ago You may also like 31:01 Pre-Clinical Animal Models 5 years ago Conferences & Meetings,Foundations of Drug Development 16:45 Optimizing Clinical Trials 5 years ago Conferences & Meetings,Foundations of Drug Development 23:07 Participation in Clinical Trials 5 years ago Conferences & Meetings,Foundations of Drug Development 20:26 FibroGen 5 years ago Conferences & Meetings,In the Pipeline: Combating Fibrosis & Inflammation 22:59 Italfarmaco 5 years ago Conferences & Meetings,In the Pipeline: Combating Fibrosis & Inflammation 21:06 Capricor Therapeutics 5 years ago Conferences & Meetings,In the Pipeline: Combating Fibrosis & Inflammation 18:40 Sarepta Therapeutics 5 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy 17:20 Pfizer Inc. 5 years ago Conferences & Meetings,In the Pipeline: Gene Therapy gene therapy «1…2021222324…28»Page 22 of 28